30 h. ago China’s biotech firms record surge in overseas licensing deals in first quarter

Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion.

Economics

4 d. ago Bangladesh’s ‘remittance warriors’ deliver record US$3 billion boost

The surge in money being sent home by overseas workers is a vote of confidence in his Muhammad Yunus’ transitional government, observers say.

Economics

8 d. ago Top US money managers stay upbeat on Chinese stocks amid AI, biotech boom

Top US money managers stay upbeat on Chinese stocks amid AI, biotech boom  South China Morning Post

Politics

1 week ago Novo adds to obesity drug pipeline via $200M deal with China

Novo adds to obesity drug pipeline via $200M deal with China-based biotech  BioPharma Dive

Economics

2 w. ago AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts

AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts  Fierce Biotech

Politics

2 w. ago American demand for overseas property, residency surges in second Trump term

UK, Portugal and Australia see influx as investment migration becomes ‘essential insurance’ against uncertainty, consultant says.

Politics

2 w. ago Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US rivalry

Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US rivalry  South China Morning Post

Events

3 w. ago Illumina aims to cut $100M in costs following China import ban

Illumina aims to cut $100M in costs following China import ban  Fierce Biotech

Economics